In vitro activities of rifamycin derivatives ABI-1648 (Rifalazil, KRM-1648), ABI-1657, and ABI-1131 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae (Q37870051)
Jump to navigation
Jump to search
scientific article published on March 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | In vitro activities of rifamycin derivatives ABI-1648 (Rifalazil, KRM-1648), ABI-1657, and ABI-1131 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae |
scientific article published on March 2003 |
Statements
1 reference
In vitro activities of rifamycin derivatives ABI-1648 (Rifalazil, KRM-1648), ABI-1657, and ABI-1131 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae (English)
1 reference
Chlamydia pneumoniae
1 reference
Patricia M Roblin
1 reference
Tamara Reznik
1 reference
Andrei Kutlin
1 reference
Margaret R Hammerschlag
1 reference
1 March 2003
1 reference
1 reference
1135-1136
1 reference
Identifiers
1 reference
1 reference
1 reference